Nonheme oxoiron(IV) complexes of two pentadentate ligands, N4Py (N,N-bis(2-pyridylmethyl)-bis(2-pyridyl)methylamine) and Bn-tpen (N-benzyl-N,N',N'-tris(2-pyridylmethyl)-1,2-diaminoethane), have been generated and found to have spectroscopic properties similar to the closely related tetradentate TPA (tris(2-pyridylmethyl)amine) complex reported earlier. However, unlike the TPA complex, the pentadentate complexes have a considerable lifetime at room temperature. This greater thermal stability has allowed the hydroxylation of alkanes with C-H bonds as strong as 99.3 kcal/mol to be observed at room temperature. Furthermore, a large deuterium KIE value is found in the oxidation of ethylbenzene. These observations lend strong credence to postulated mechanisms of mononuclear nonheme iron enzymes that invoke the intermediacy of oxoiron(IV) species.
The coordinatively unsaturated sites in MIL‐101, Cr3(F,OH)(H2O)2O[(O2C)‐C6H4‐(CO2)]3⋅n H2O (n≈25), having zeotypic giant pores can be selectively functionalized in a way differing from that of mesoporous silica. Metal–organic frameworks, grafted with ethylenediamine or diethylenetriamine on the unsaturated CrIII sites of MIL‐101, exhibit remarkably high activities in the Knoevenagel condensation relative to that of the mesophase.
The oxygenation of carbon-carbon double bonds by iron enzymes generally results in the formation of epoxides, except in the case of the Rieske dioxygenases, where cis-diols are produced. Herein we report a systematic study of olefin oxidations with H(2)O(2) catalyzed by a group of non-heme iron complexes, i.e., [Fe(II)(BPMEN)(CH(3)CN)(2)](2+) (1, BPMEN = N,N'-dimethyl-N,N'-bis(2-pyridylmethyl)-1,2-diaminoethane) and [Fe(II)(TPA)(CH(3)CN)(2)](2+) (4, TPA = tris(2-pyridylmethyl)amine) and their 6- and 5-methyl-substituted derivatives. We demonstrate that olefin epoxidation and cis-dihydroxylation are different facets of the reactivity of a common Fe(III)-OOH intermediate, whose spin state can be modulated by the electronic and steric properties of the ligand environment. Highly stereoselective epoxidation is favored by catalysts with no more than one 6-methyl substituent, which give rise to low-spin Fe(III)-OOH species (category A). On the other hand, cis-dihydroxylation is favored by catalysts with more than one 6-methyl substituent, which afford high-spin Fe(III)-OOH species (category B). For catalysts in category A, both the epoxide and the cis-diol product incorporate (18)O from H(2)(18)O, results that implicate a cis-H(18)O-Fe(V)=O species derived from O-O bond heterolysis of a cis-H(2)(18)O-Fe(III)-OOH intermediate. In contrast, catalysts in category B incorporate both oxygen atoms from H(2)(18)O(2) into the dominant cis-diol product, via a putative Fe(III)-eta(2)-OOH species. Thus, a key feature of the catalysts in this family is the availability of two cis labile sites, required for peroxide activation. The olefin epoxidation and cis-dihydroxylation studies described here not only corroborate the mechanistic scheme derived from our earlier studies on alkane hydroxylation by this same family of catalysts (Chen, K.; Que, L, Jr. J. Am. Chem. Soc. 2001, 123, 6327) but also further enhance its credibility. Taken together, these reactions demonstrate the catalytic versatility of these complexes and provide a rationale for Nature's choice of ligand environments in biocatalysts that carry out olefin oxidations.
Our efforts to model the oxygen activation chemistry
of nonheme iron enzymes have yielded transient
intermediates with novel properties. These properties can be
dramatically affected by the introduction of a 6-methyl
substituent on the pendant pyridines of the tetradentate ligand TPA
(TPA = tris(2-pyridylmethyl)amine). A
series
of Fe(TPA) complexes has thus been synthesized and characterized
to provide the structural basis for these dramatic
effects. The following complexes have been obtained:
[Fe(L)(CH3CN)2](ClO4)2
(1, L = TPA; 2, L = 6-MeTPA;
3, L = 6-Me2TPA; 4, L =
6-Me3TPA) and
[Fe(L)(acac)](ClO4)2 (5,
L = TPA; 6, L = 5-Me3TPA;
7, L = 6-MeTPA).
As indicated by 1H NMR and/or EPR, 1,
5, and 6 with no 6-methyl substituent are low
spin, while complexes 2, 3,
4, and 7 with at least one 6-methyl substituent
are all high spin, with higher redox potentials than their
low-spin
counterparts. The ligands with 6-methyl substituents thus favor a
metal center with a larger ionic radius, i.e.,
FeII
over FeIII and high spin over low spin. Careful
scrutiny of the crystal structures of 1, 4,
6, and 7 reveals that one
hydrogen of the 6-methyl group is only 2.7 Å away from the metal
center in the high-spin complexes. Its presence
thus prevents the pyridine nitrogen from forming an Fe−N bond shorter
than 2.1 Å as required for an iron center to
adopt a low-spin configuration. This steric effect of the 6-methyl
substituent serves as a simple but very useful
ligand design tool to tune the electronic properties of the metastable
alkylperoxoiron(III) species derived from the
reactions of 1−4 with tert-butyl
hydroperoxide. These intermediates serve as models for low-spin
and high-spin
peroxoiron(III) species in the reaction cycles of the antitumor
drug bleomycin and lipoxygenase, respectively.
Similar
principles apply in the design of nonheme diiron(II) complexes
that reversibly bind dioxygen and of high-valent
bis(μ-oxo)diiron complexes that model the high-valent
intermediates in the redox cycles of nonheme diiron
enzymes
such as methane monooxygenase and ribonucleotide
reductase.
The photocatalyst-enzyme coupled system for artificial photosynthesis process is one of the most promising methods of solar energy conversion for the synthesis of organic chemicals or fuel. Here we report the synthesis of a novel graphene-based visible light active photocatalyst which covalently bonded the chromophore, such as multianthraquinone substituted porphyrin with the chemically converted graphene as a photocatalyst of the artificial photosynthesis system for an efficient photosynthetic production of formic acid from CO(2). The results not only show a benchmark example of the graphene-based material used as a photocatalyst in general artificial photosynthesis but also the benchmark example of the selective production system of solar chemicals/solar fuel directly from CO(2).
Die koordinativ ungesättigten Positionen in MIL‐101, Cr3(F,OH)(H2O)2O[(O2C)‐C6H4‐(CO2)]3⋅n H2O (n≈25), mit zeotypen Riesenporen können auf anderem Weg als mesoporöse Kieselgele selektiv funktionalisiert werden. Metall‐organische Gerüste mit Ethylendiamin oder Diethylentriamin an den ungesättigten CrIII‐Positionen von MIL‐101 sind im Vergleich zur Mesophase bemerkenswert aktiv bei der Knoevenagel‐Kondensation.
There is an intriguing, current controversy on the involvement of iron(III)-hydroperoxo species as a "second electrophilic oxidant" in oxygenation reactions by heme and non-heme iron enzymes and their model compounds. In the present work, we have performed reactivity studies of the iron-hydroperoxo species in nucleophilic and electrophilic reactions, with in situ-generated mononuclear non-heme iron(III)-hydroperoxo complexes that have been well characterized with various spectroscopic techniques. The intermediates did not show any reactivities in the nucleophilic (e.g., aldehyde deformylation) and electrophilic (e.g., oxidation of sulfide and olefin) reactions. These results demonstrate that non-heme iron(III)-hydroperoxo species are sluggish oxidants and that the oxidizing power of the intermediates cannot compete with that of high-valent iron(IV)-oxo complexes. We have also reported reactivities of mononuclear non-heme iron(III)-peroxo and iron(IV)-oxo complexes in the aldehyde deformylation and the oxidation of sulfides, respectively.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.